Literature DB >> 31434799

NOX4 modulates macrophage phenotype and mitochondrial biogenesis in asbestosis.

Chao He1, Jennifer L Larson-Casey1, Dana Davis1, Vidya Sagar Hanumanthu2, Ana Leda F Longhini2, Victor J Thannickal1,3, Linlin Gu1, A Brent Carter1,3.   

Abstract

Macrophage activation is implicated in the development of pulmonary fibrosis by generation of profibrotic molecules. Although NADPH oxidase 4 (NOX4) is known to contribute to pulmonary fibrosis, its effects on macrophage activation and mitochondrial redox signaling are unclear. Here, we show that NOX4 is crucial for lung macrophage profibrotic polarization and fibrotic repair after asbestos exposure. NOX4 was elevated in lung macrophages from subjects with asbestosis, and mice harboring a deletion of NOX4 in lung macrophages were protected from asbestos-induced fibrosis. NOX4 promoted lung macrophage profibrotic polarization and increased production of profibrotic molecules that induce collagen deposition. Mechanistically, NOX4 further augmented mitochondrial ROS production and induced mitochondrial biogenesis. Targeting redox signaling and mitochondrial biogenesis prevented the profibrotic polarization of lung macrophages by reducing the production of profibrotic molecules. These observations provide evidence that macrophage NOX4 is a potentially novel therapeutic target to halt the development of asbestos-induced pulmonary fibrosis.

Entities:  

Keywords:  Bioenergetics; Immunology; Macrophages; Mitochondria; Pulmonology

Mesh:

Substances:

Year:  2019        PMID: 31434799      PMCID: PMC6777818          DOI: 10.1172/jci.insight.126551

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  54 in total

1.  NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-derived 2-like 2 (Nrf2)-dependent Pathway.

Authors:  Karen Bernard; Naomi J Logsdon; Veronica Miguel; Gloria A Benavides; Jianhua Zhang; A Brent Carter; Victor M Darley-Usmar; Victor J Thannickal
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

2.  Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome.

Authors:  Lisa R Young; Peter M Gulleman; Chelsi W Short; Harikrishna Tanjore; Taylor Sherrill; Aidong Qi; Andrew P McBride; Rinat Zaynagetdinov; John T Benjamin; William E Lawson; Sergey V Novitskiy; Timothy S Blackwell
Journal:  JCI Insight       Date:  2016-10-20

3.  Mitochondrial Rac1 GTPase import and electron transfer from cytochrome c are required for pulmonary fibrosis.

Authors:  Heather L Osborn-Heaford; Alan J Ryan; Shubha Murthy; Ana-Monica Racila; Chao He; Jessica C Sieren; Douglas R Spitz; A Brent Carter
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

4.  The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species.

Authors:  Evan A Bordt; Pascaline Clerc; Brian A Roelofs; Andrew J Saladino; László Tretter; Vera Adam-Vizi; Edward Cherok; Ahmed Khalil; Nagendra Yadava; Shealinna X Ge; T Chase Francis; Nolan W Kennedy; Lora K Picton; Tanya Kumar; Sruti Uppuluri; Alexandrea M Miller; Kie Itoh; Mariusz Karbowski; Hiromi Sesaki; R Blake Hill; Brian M Polster
Journal:  Dev Cell       Date:  2017-03-27       Impact factor: 12.270

5.  NADPH oxidase 4 mediates monocyte priming and accelerated chemotaxis induced by metabolic stress.

Authors:  Sarah Ullevig; Qingwei Zhao; Chi Fung Lee; Hong Seok Kim; Debora Zamora; Reto Asmis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

6.  Mitochondrial Cu,Zn-superoxide dismutase mediates pulmonary fibrosis by augmenting H2O2 generation.

Authors:  Chao He; Shubha Murthy; Michael L McCormick; Douglas R Spitz; Alan J Ryan; A Brent Carter
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

7.  NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

Authors:  Junya Kuroda; Tetsuro Ago; Shouji Matsushima; Peiyong Zhai; Michael D Schneider; Junichi Sadoshima
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

8.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

9.  Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span.

Authors:  Alexander V Misharin; Luisa Morales-Nebreda; Paul A Reyfman; Carla M Cuda; James M Walter; Alexandra C McQuattie-Pimentel; Ching-I Chen; Kishore R Anekalla; Nikita Joshi; Kinola J N Williams; Hiam Abdala-Valencia; Tyrone J Yacoub; Monica Chi; Stephen Chiu; Francisco J Gonzalez-Gonzalez; Khalilah Gates; Anna P Lam; Trevor T Nicholson; Philip J Homan; Saul Soberanes; Salina Dominguez; Vince K Morgan; Rana Saber; Alexander Shaffer; Monique Hinchcliff; Stacy A Marshall; Ankit Bharat; Sergejs Berdnikovs; Sangeeta M Bhorade; Elizabeth T Bartom; Richard I Morimoto; William E Balch; Jacob I Sznajder; Navdeep S Chandel; Gökhan M Mutlu; Manu Jain; Cara J Gottardi; Benjamin D Singer; Karen M Ridge; Neda Bagheri; Ali Shilatifard; G R Scott Budinger; Harris Perlman
Journal:  J Exp Med       Date:  2017-07-10       Impact factor: 14.307

10.  Reduced oxidative capacity in macrophages results in systemic insulin resistance.

Authors:  Saet-Byel Jung; Min Jeong Choi; Dongryeol Ryu; Hyon-Seung Yi; Seong Eun Lee; Joon Young Chang; Hyo Kyun Chung; Yong Kyung Kim; Seul Gi Kang; Ju Hee Lee; Koon Soon Kim; Hyun Jin Kim; Cuk-Seong Kim; Chul-Ho Lee; Robert W Williams; Hail Kim; Heung Kyu Lee; Johan Auwerx; Minho Shong
Journal:  Nat Commun       Date:  2018-04-19       Impact factor: 14.919

View more
  17 in total

1.  NOX4 Mediates Epithelial Cell Death in Hyperoxic Acute Lung Injury Through Mitochondrial Reactive Oxygen Species.

Authors:  Anantha Harijith; Prathima Basa; Alison Ha; Jaya Thomas; Anjum Jafri; Panfeng Fu; Peter M MacFarlane; Thomas M Raffay; Viswanathan Natarajan; Tara Sudhadevi
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

Review 2.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

Review 3.  Mitochondrial quality control in pulmonary fibrosis.

Authors:  Jennifer L Larson-Casey; Chao He; A Brent Carter
Journal:  Redox Biol       Date:  2020-01-08       Impact factor: 11.799

Review 4.  NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis.

Authors:  Kosuke Kato; Louise Hecker
Journal:  Redox Biol       Date:  2020-04-17       Impact factor: 11.799

5.  SIRT3 Overexpression Ameliorates Asbestos-Induced Pulmonary Fibrosis, mt-DNA Damage, and Lung Fibrogenic Monocyte Recruitment.

Authors:  Paul Cheresh; Seok-Jo Kim; Renea Jablonski; Satoshi Watanabe; Ziyan Lu; Monica Chi; Kathryn A Helmin; David Gius; G R Scott Budinger; David W Kamp
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

Review 6.  Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis.

Authors:  Marta Bueno; Jazmin Calyeca; Mauricio Rojas; Ana L Mora
Journal:  Redox Biol       Date:  2020-03-19       Impact factor: 11.799

7.  The Sphingosine Kinase 1 Inhibitor, PF543, Mitigates Pulmonary Fibrosis by Reducing Lung Epithelial Cell mtDNA Damage and Recruitment of Fibrogenic Monocytes.

Authors:  Paul Cheresh; Seok-Jo Kim; Long Shuang Huang; Satoshi Watanabe; Nikita Joshi; Kinola J N Williams; Monica Chi; Ziyan Lu; Anantha Harijith; Anjana Yeldandi; Anna P Lam; Cara Gottardi; Alexander V Misharin; G R Scott Budinger; Viswanathan Natarajan; David W Kamp
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

8.  C(C)Learing the Role of Chemokines in Pulmonary Fibrosis.

Authors:  Chao He; A Brent Carter
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

9.  Post-translational regulation of PGC-1α modulates fibrotic repair.

Authors:  Jennifer L Larson-Casey; Linlin Gu; Dana Davis; Guo-Qiang Cai; Qiang Ding; Chao He; A Brent Carter
Journal:  FASEB J       Date:  2021-06       Impact factor: 5.191

Review 10.  Raising the 'Good' Oxidants for Immune Protection.

Authors:  Alexia Dumas; Ulla G Knaus
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.